Gene · 353
Papers3,627
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 3,627
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genetic variations in human ATP2B4 gene alter Plasmodium falciparum in vitro growth in RBCs from Gambian adults. | Malar J | 2023 | 36604655 | PubTator, text mining | PubMed |
| Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models. | Clin Cancer Res | 2023 | 36602782 | PubTator, text mining | PubMed |
| Adenosine-Dependent Activation Mechanism of Prodrugs Targeting an Aminoacyl-tRNA Synthetase. | J Am Chem Soc | 2023 | 36599057 | PubTator, text mining | PubMed |
| Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA. | Cancer Discov | 2023 | 36598417 | PubTator, text mining | PubMed |
| Recent progress in the development of nanomaterials targeting multiple cancer metabolic pathways: a review of mechanistic approaches for cancer treatment. | Drug Deliv | 2023 | 36597205 | PubTator, text mining | PubMed |
| Pan-Cancer analyses of Necroptosis-Related genes as a potential target to predict immunotherapeutic outcome. | J Cell Mol Med | 2023 | 36583248 | PubTator, text mining | PubMed |
| Integrated View of Baseline Protein Expression in Human Tissues. | J Proteome Res | 2023 | 36577097 | PubTator, text mining | PubMed |
| A case of 2,8-DHA crystalline nephropathy caused by adenine phosphoribosyltransferase deficiency: diagnosis and treatment. | CEN Case Rep | 2023 | 36576711 | PubTator, text mining | PubMed |
| Accessing clinical-grade genomic classification data through the ClinGen Data Platform. | Pac Symp Biocomput | 2023 | 36541006 | PubTator, text mining | PubMed |
| Targeted gene panel analysis of Japanese patients with maturity-onset diabetes of the young-like diabetes mellitus: Roles of inactivating variants in the ABCC8 and insulin resistance genes. | J Diabetes Investig | 2023 | 36504295 | PubTator, text mining | PubMed |
| Molecular Biomarkers of Disease Outcomes and Mechanisms of Acquired Resistance to First-Line Osimertinib in Advanced EGFR-Mutant Lung Cancers. | J Thorac Oncol | 2023 | 36494075 | PubTator, text mining | PubMed |
| AMP-BERT: Prediction of antimicrobial peptide function based on a BERT model. | Protein Sci | 2023 | 36461699 | PubTator, text mining | PubMed |
| Amp(1q) and tetraploidy are commonly acquired chromosomal abnormalities in relapsed multiple myeloma. | Eur J Haematol | 2023 | 36433728 | PubTator, text mining | PubMed |
| Genetic alterations of TP53 and OTX2 indicate increased risk of relapse in WNT medulloblastomas: "it's a numbers game"-implications for WNT medulloblastoma dose-reduction clinical trials. | Acta Neuropathol | 2023 | 36403175 | PubTator, text mining | PubMed |
| Proteomics uncover EPHA2 as a potential novel therapeutic target in colorectal cancer cell lines with acquired cetuximab resistance. | J Cancer Res Clin Oncol | 2023 | 36401637 | PubTator, text mining | PubMed |
| Genetic Profiling of Diffuse Large B-Cell Lymphoma: A Comparison Between Double-Expressor Lymphoma and Non-Double-Expressor Lymphoma. | Mol Diagn Ther | 2023 | 36401148 | PubTator, text mining | PubMed |
| Crystalline Anions Based on Classical N-Heterocyclic Carbenes. | Angew Chem Int Ed Engl | 2023 | 36398890 | PubTator, text mining | PubMed |
| Gut microbiota affects brain development and behavior. | Clin Exp Pediatr | 2023 | 36397259 | PubTator, text mining | PubMed |
| GALC variants affect galactosylceramidase enzymatic activity and risk of Parkinson's disease. | Brain | 2023 | 36370000 | PubTator, text mining | PubMed |
| Osimertinib + Savolitinib to Overcome Acquired MET-Mediated Resistance in Epidermal Growth Factor Receptor-Mutated, MET-Amplified Non-Small Cell Lung Cancer: TATTON. | Cancer Discov | 2023 | 36264123 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/353/papers?page=19